TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 117 filers reported holding TCR2 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $166,500 | -33.2% | 111,000 | -55.5% | 0.00% | -100.0% |
| Q4 2022 | $249,353 | -64.9% | 249,653 | -36.7% | 0.00% | -50.0% |
| Q3 2022 | $710,000 | -46.2% | 394,600 | -13.2% | 0.00% | -50.0% |
| Q2 2022 | $1,319,000 | -33.0% | 454,700 | -36.2% | 0.00% | -20.0% |
| Q1 2022 | $1,968,000 | -28.8% | 713,100 | +20.2% | 0.01% | -28.6% |
| Q4 2021 | $2,765,000 | +70.6% | 593,400 | +211.5% | 0.01% | +75.0% |
| Q3 2021 | $1,621,000 | -64.5% | 190,500 | -31.6% | 0.00% | -66.7% |
| Q2 2021 | $4,572,000 | -30.0% | 278,600 | -5.9% | 0.01% | -33.3% |
| Q1 2021 | $6,536,000 | +232.3% | 296,000 | +365.4% | 0.02% | +260.0% |
| Q4 2020 | $1,967,000 | – | 63,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
| Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
| Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
| Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
| PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
| Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
| MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
| Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |